Study to Assess Safety and Performance of Neola®, a Novel Lung Monitoring Device for Neonates

NCT06917326 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-03-18

No results posted yet for this study

Summary

Clinical pilot study to assess safety and performance of Neola®, a novel lung monitoring device for neonates

Conditions

Interventions

DEVICE

Monitoring

Lung monitoring with the Neola device

Sponsors & Collaborators

  • Neola Medical AB

    lead INDUSTRY

Principal Investigators

  • Gustaf Lernfelt · Sodra Alvsborgs Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Day
Max Age
14 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-20
Primary Completion
2026-03-12
Completion
2026-03-12

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06917326 on ClinicalTrials.gov